Tag:
Versartis
Latest Headlines
Latest Headlines
Versartis grabs $21M Series B, aims to begin study of once-monthly hormone therapy
Investors have injected a $21 million second round of venture money into Versartis, a company that focuses on long-acting release treatments for endocrine disorders. With the new round, the Mountain
Upstart Versartis nabs $21M in Series B cash
With its lead therapy poised to begin a Phase I study, Mountain View, CA-based start-up Versartis has hauled in $21 million in its second round of venture cash. The money will be earmarked for the
Start-up Versartis snags $11M for upcoming trials
Versartis, a start-up developer created late last year as a joint venture between Amunix and Index Ventures, has raised $11 million in the first close of a Series A that could later swell to $16
